Table 3.
Comparison of preoperative laboratory indicators between the two groups.
| Variables | Without POP (N = 1945) | With POP (N = 53) | P value |
|---|---|---|---|
| TP < 65 g/L, n (%) | 1185 (82.2) | 47 (88.7) | 0.222 |
| ALB < 35 g/L, n (%) | 975 (67.6) | 37 (69.8) | 0.737 |
| GLOB (references 20–40 g/L), n (%) | 0.693 | ||
| < 20 | 228 (15.8) | 7 (13.2) | |
| > 40 | 12 (0.8) | 0 (0.0) | |
| A/G (references 1.2–2.4), n (%) | 0.676 | ||
| < 1.2 | 314 (21.8) | 13 (24.5) | |
| > 2.4 | 16 (1.1) | 0 (0.0) | |
| ALT (references 9–50 U/L), n (%) | 0.431 | ||
| < 9 | 162 (11.2) | 8 (15.1) | |
| > 50 | 72 (5.0) | 1 (1.9) | |
| AST (references 15–40 U/L), n (%) | 0.807 | ||
| < 15 | 269 (18.7) | 9 (17.0) | |
| > 40 | 140 (9.7) | 4 (7.5) | |
| TBIL (> 26), n (%) | 192 (13.3) | 9 (17.0) | 0.442 |
| DBIL (> 6), n (%) | 648 (44.9) | 30 (56.6) | 0.145 |
| IBIL (> 14), n (%) | 242 (16.8) | 10 (18.9) | 0.061 |
| ALP (references 45–125 U/L), n (%) | 0.720 | ||
| < 45 | 169 (11.7) | 7 (13.2) | |
| > 125 | 92 (6.4) | 2 (3.8) | |
| GGT (references 10–60 U/L), n (%) | 0.936 | ||
| < 10 | 83 (5.8) | 3 (5.7) | |
| > 60 | 116 (8.0) | 5 (9.4) | |
| CHE (references 5–12 U/L), n (%) | 0.254 | ||
| < 2 | 627 (43.5) | 29 (54.7) | |
| > 12 | 5 (0.3) | 0 (0.0) | |
| TBA (references 1–10 μmol/L), n (%) | 0.411 | ||
| < 1 | 91 (6.3) | 3 (5.7) | |
| > 10 | 164 (11.4) | 3 (5.7) | |
| HCRP (> 8 mg/L), n (%) | 1210 (83.9) | 45 (84.9) | 0.846 |
| CK (> 310 U/L), n (%) | 297 (20.6) | 11 (20.8) | 0.978 |
| CKMB (> 20 U/L), n (%) | 219 (15.2) | 14 (26.4) | 0.027 |
| LDH (> 250 U/L), n (%) | 461 (32.0) | 16 (30.2) | 0.785 |
| TC (> 5.2 μmol/L), n (%) | 95 (6.6) | 2 (3.8) | 0.414 |
| TG (> 1.7 μmol/L), n (%) | 99 (6.9) | 4 (7.5) | 0.847 |
| Na (references 137–147 mmol/L), n (%) | 0.471 | ||
| < 137 | 663 (46.0) | 26 (49.1) | |
| > 147 | 9 (0.6) | 1 (1.9) | |
| K (references 3.5–5.3 mmol/L), n (%) | 0.610 | ||
| < 3.5 | 205 (14.2) | 6 (11.3) | |
| > 5.3 | 16 (1.1) | 0 (0.0) | |
| CL (references 99–110 mmol/L), n (%) | 0.050 | ||
| < 99 | 225 (15.6) | 65 (4.5) | |
| > 110 | 65 (4.5) | 6 (11.3) | |
| TCO2 (references 20–30 mmol/L), n (%) | 0.889 | ||
| < 20 | 69 (4.8) | 3 (5.7) | |
| > 30 | 721 (5.0) | 2 (3.8) | |
| GLU (> 6.1), n (%) | 868 (60.2) | 34 (64.2) | 0.761 |
| UREA (> 8), n (%) | 327 (22.8) | 15 (28.3) | 0.320 |
| CREA (references 57–97 mmol/L), n (%) | 0.563 | ||
| < 57 | 623 (43.2) | 20 (37.7) | |
| > 97 | 92 (6.4) | 5 (9.4) | |
| UA (references 208–428 mmol/L), n (%) | 0.302 | ||
| < 208 | 729 (40.6) | 22 (41.5) | |
| > 428 | 44 (3.1) | 3 (5.7) | |
| CA (references 2.11–2.52 mmol/L), n (%) | 0.600 | ||
| < 2.11 | 761 (52.8) | 31 (58.5) | |
| > 2.52 | 12 (0.8) | 0 (0.0) | |
| P (references 0.85–1.51 mmol/L), n (%) | 0.579 | ||
| < 0.85 | 185 (12.8) | 9 (17.0) | |
| > 1.51 | 50 (3.5) | 1 (1.9) | |
| Mg (references 0.75–1.02 mmol/L), n (%) | 0.671 | ||
| < 0.75 | 167 (11.6) | 44 (3.1) | |
| > 1.02 | 8 (15.1) | 1 (1.9) | |
| BNP (ng/L), n (%) | < 0.001 | ||
| < 75 | 558 (38.7) | 9 (17.0) | |
| > 75 | 416 (28.8) | 30 (56.6) | |
| Unknown | 468 (32.5) | 14 (26.4) | |
| WBC (references 3.5–9.5 × 109/L), n (%) | 0.307 | ||
| < 3.5 | 10 (0.7) | 0 (0.0) | |
| > 9.5 | 513 (35.6) | 24 (45.3) | |
| NEU (references 2.8–6.3 × 109/L), n (%) | 0.071 | ||
| < 1.8 | 3 (0.3) | 0 (0.0) | |
| > 6.3 | 749 (51.9) | 36 (67.9) | |
| LYM (references 1.1–3.2 × 109/L), n (%) | 0.818 | ||
| < 1.1 | 752 (52.1) | 29 (54.7) | |
| > 3.2 | 8 (0.6) | 0 (0) | |
| MON (references 0.1–0.6 × 109/L), n (%) | 0.520 | ||
| < 0. 1 | 3 (0.2) | 0 (0) | |
| > 0.6 | 870 (60.3) | 36 (67.9) | |
| EOS (references 0.02–0.05 × 109/L), n (%) | 0.052 | ||
| < 0.02 | 373 (25.9) | 9 (17.0) | |
| > 0.52 | 4 (0.3) | 1 (1.9) | |
| BAS (> 0.06), n (%) | 83 (5.8) | 3 (5.7) | 0.977 |
| RBC (> 5.8), n (%) | 94 (6.5) | 4 (7.5) | 0.766 |
| NEU% (references 45–75%), n (%) | 0.650 | ||
| < 45 | 3 (0.2) | 0 (0.0) | |
| > 75 | 865 (60.0) | 35 (66.0) | |
| LYM% (> 5.2), n (%) | 1378 (95.6) | 50 (94.3) | 0.673 |
| MON% (references 3–10%), n (%) | 0.638 | ||
| < 3 | 24 (1.7) | 0 (0.0) | |
| > 10 | 343 (23.8) | 13 (24.5) | |
| BAS% (> 1%), n (%) | 10 (0.7) | 11 (0.7) | 0.318 |
| HGB (< 110/120 g/L), n (%) | 1334 (92.5) | 50 (94.3) | 0.618 |
| MCV (references 82–100 fL), n (%) | 0.086 | ||
| < 82 | 31 (2.1) | 0 (0.0) | |
| > 100 | 110 (7.6) | 8 (15.1) | |
| MCH (references 27–34 pg), n (%) | 0.189 | ||
| < 27 | 38 (2.6) | 0 (0.0) | |
| > 34 | 92 (6.4) | 6 (11.3) | |
| MCHC (references 316–354 g/L), n (%) | 0.074 | ||
| < 316 | 38 (2.6) | 3 (5.7) | |
| > 354 | 61 (4.2) | 5 (9.4) | |
| RDW (references 11.6–16.5%), n (%) | 0.912 | ||
| < 11.6 | 5 (0.3) | 0 (0.0) | |
| > 16.5 | 136 (9.4) | 5 (9.4) | |
| PLT (references 125–350 × 109/L), n (%) | 0.996 | ||
| < 125 | 135 (9.4) | 5 (9.4) | |
| > 250 | 86 (6.0) | 3 (5.7) | |
| MPV (references 7.4–11.0 fL), n (%) | 0.246 | ||
| < 7.4 | 227 (15.7) | 12 (22.6) | |
| > 11.0 | 49 (3.4) | 3 (5.7) | |
| PCT (references 0.16–0.43%), n (%) | 0.010 | ||
| < 0.16 | 937 (65.0) | 34 (64.2) | |
| > 0.43 | 7 (0.5) | 2 (3.8) | |
| PDW (references 12.0–18.1%), n (%) | 0.934 | ||
| < 7.4 | 130 (9.0) | 4 (7.5) | |
| > 11.0 | 26 (1.8) | 1 (1.9) | |
| PT (> 12.5 S), n (%) | 333 (23.1) | 10 (18.9) | 0.246 |
| PTA (< 80%), n (%) | 175 (12.1) | 7 (13.2) | 0.873 |
| INR (> 1.4%), n (%) | 11 (0.8) | 1 (1.9) | 0.368 |
| APTT (references 28–42 S), n (%) | 0.934 | ||
| < 28 | 500 (34.7) | 24 (45.3) | |
| > 42 | 20 (1.4) | 0 (0.0) | |
| APTT-R (references 0.7–1.3), n (%) | 0.528 | ||
| < 0.7 | 18 (1.2) | 0 (0.0) | |
| > 1.3 | 16 (1.1) | 0 (0.0) | |
| TT (references 14–21 S), n (%) | 0.696 | ||
| < 14 | 1026 (71.2) | 35 (66.0) | |
| > 21 | 151 (10.5) | 6 (11.3) | |
| FIB (reference 2.0–4.4 mg/L), n (%) | 0.708 | ||
| < 2.0 | 16 (1.1) | 0 (0.0) | |
| > 4.4 | 350 (24.3) | 14 (26.4) | |
| ATIII (reference 80–120%), n (%) | 0.916 | ||
| < 80 | 295 (20.5) | 12 (22.6) | |
| > 120 | 33 (2.3) | 1 (1.9) | |
| D-Dimer (> 2.26 mg/L), n (%) | 571 (39.6) | 34 (64.2) | < 0.001 |
ASA American Society of Anesthesiologists, BMI body mass index, TP total protein, ALB albumin, GLOB globulin, A/G values albumin/globulin, ALT alanine transaminase, AST aspartate aminotransferase, TBIL total bilirubin, DBIL direct bilirubin, IBIL indirect bilirubin, ALP alkaline phosphatase, GGT γ-glutamyl transpeptidase, CHE cholinesterase, TBA total bile acid, HCRP hypersensitive c-reactive protein, LDH lactate dehydrogenase, CREA creatinine, UA uric acid, CA calcium, P phosphorus, Mg magnesium, BNP brain natriuretic peptide, WBC white blood cell, NEUT neutrophile, LYM lymphocyte, MON mononuclear cell, EOS eosinophilic granulocyte, BAS basophilic granulocyte, RBC red blood cell, reference range: female, 3.5–5.0 × 1012/L; males, 4.0–5.5 × 1012/L. HGB hemoglobin, reference range: females, 110–150 g/L; males, 120–160 g/L, HCT haematocrit, 40–50%, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, RDW red blood cell distribution width, PLT platelet, 100–300 × 109/L, MPV mean platelet volume, PCT procalcitonin, pdw platelet distribution width, PT prothrombin time, PTA prothrombin activity, INR international normalized ratio, APTT activated partial thromboplastin time, APTT-R activated partial thromboplastin time ratio, TT thrombin time, TT-R thrombin ratio, FIB fibrinogen, ATIII antithrombin III.